Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 265

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes

Open access
Isabwe, Ghislaine Annie C., Garcia Neuer, Marlene, de las Vecillas Sanchez, Leticia, Lynch, Donna-Marie, Marquis, Kathleen, Castells, Mariana·2018·Journal of Allergy and Clinical Immunology

Abstract

Background: The increasing use of mAbs has led to a rise in hypersensitivity reactions (HSRs), which prevent their use as first‐line therapy. HSRs' symptoms, diagnostic tools, and directed management approaches have not been standardized. Objective: We propose a novel evidence‐based classification of HSRs to mAbs, based on the clinical phenotypes, underlying endotypes and biomarkers, as well as their management with desensitization. Methods: Phenotypes, endotypes, and biomarkers of HSRs to 16 mAbs for 104 patients were described and compared with the outcomes of 526 subcutaneous and intravenous desensitizations. Results: Initial reactions presented with 4 patterns: type I–like reactions (63%), cytokine‐release reactions (13%), mixed reactions (21%), and delayed type IV reactions (3%). In contrast, of the 23% breakthrough HSRs during desensitization, 52% were cytokine‐release reactions, 32% were type 1, 12% were mixed, and 4% were type I with delayed type IV. Skin testing to 10 mAbs in 58 patients was positive in 41% of patients. Serum tryptase was elevated in 1 patient and IL‐6 was elevated in 8 patients during desensitization and was associated with a cytokine‐release phenotype. Conclusions: HSRs to mAbs can be defined as type I, cytokine‐release, mixed (type I/cytokine‐release), and type IV reactions, which are identified by biomarkers such as skin test, tryptase, and IL‐6. These phenotypes can be used to improve personalized and precision medicine when diagnosing HSRs to mAbs and providing management recommendations with desensitization. Desensitization provides a safe and effective retreatment option to remain on culprit mAbs as first‐line therapy. GRAPHICAL ABSTRACT Figure. No caption available.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2018.02.018

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 265

Metadata

Authors
Isabwe, G. A. C., Garcia Neuer, M., de las Vecillas Sanchez, L., Lynch, D.-M., Marquis, K., & Castells, M.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2018-07
Volume
142
Issue
1
Pages
159-170.e2
ISSN
0091-6749 (ISSN-L)
OpenAlex
W2791685657
Cited by
265
References
32
FWCI
12.72
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes. https://app.cochat.ai/papers/10.1016/j.jaci.2018.02.018
The paper
Isabwe, G. A. C., Garcia Neuer, M., de las Vecillas Sanchez, L., Lynch, D.-M., Marquis, K., & Castells, M. (2018). Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypes. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2018.02.018

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.